Halozyme Therapeutics Statistics
Total Valuation
HALO has a market cap or net worth of $12.28 billion. The enterprise value is $14.22 billion.
| Market Cap | 12.28B |
| Enterprise Value | 14.22B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HALO has 113.50 million shares outstanding. The number of shares has decreased by -4.21% in one year.
| Current Share Class | 113.50M |
| Shares Outstanding | 113.50M |
| Shares Change (YoY) | -4.21% |
| Shares Change (QoQ) | -1.35% |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 110.34% |
| Float | 112.17M |
Valuation Ratios
The trailing PE ratio is 31.98 and the forward PE ratio is 11.04.
| PE Ratio | 31.98 |
| Forward PE | 11.04 |
| PS Ratio | 7.38 |
| Forward PS | 6.06 |
| PB Ratio | 85.94 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.23 |
| P/OCF Ratio | 15.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.54, with an EV/FCF ratio of 17.64.
| EV / Earnings | 34.39 |
| EV / Sales | 8.55 |
| EV / EBITDA | 13.54 |
| EV / EBIT | 15.06 |
| EV / FCF | 17.64 |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 15.18.
| Current Ratio | 2.71 |
| Quick Ratio | 1.99 |
| Debt / Equity | 15.18 |
| Debt / EBITDA | 2.05 |
| Debt / FCF | 2.70 |
| Interest Coverage | 46.52 |
Financial Efficiency
Return on equity (ROE) is 173.67% and return on invested capital (ROIC) is 32.13%.
| Return on Equity (ROE) | 173.67% |
| Return on Assets (ROA) | 25.49% |
| Return on Invested Capital (ROIC) | 32.13% |
| Return on Capital Employed (ROCE) | 42.30% |
| Weighted Average Cost of Capital (WACC) | 7.67% |
| Revenue Per Employee | $3.93M |
| Profits Per Employee | $977,768 |
| Employee Count | 423 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.48 |
Taxes
In the past 12 months, HALO has paid $169.74 million in taxes.
| Income Tax | 169.74M |
| Effective Tax Rate | 29.10% |
Stock Price Statistics
The stock price has increased by +52.07% in the last 52 weeks. The beta is 0.85, so HALO's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +52.07% |
| 50-Day Moving Average | 83.04 |
| 200-Day Moving Average | 72.27 |
| Relative Strength Index (RSI) | 78.39 |
| Average Volume (20 Days) | 2,424,562 |
Short Selling Information
The latest short interest is 14.02 million, so 12.35% of the outstanding shares have been sold short.
| Short Interest | 14.02M |
| Short Previous Month | 13.30M |
| Short % of Shares Out | 12.35% |
| Short % of Float | 12.50% |
| Short Ratio (days to cover) | 7.87 |
Income Statement
In the last 12 months, HALO had revenue of $1.66 billion and earned $413.60 million in profits. Earnings per share was $3.38.
| Revenue | 1.66B |
| Gross Profit | 1.27B |
| Operating Income | 944.49M |
| Pretax Income | 583.34M |
| Net Income | 413.60M |
| EBITDA | 1.05B |
| EBIT | 944.49M |
| Earnings Per Share (EPS) | $3.38 |
Balance Sheet
The company has $231.00 million in cash and $2.18 billion in debt, with a net cash position of -$1.95 billion or -$17.16 per share.
| Cash & Cash Equivalents | 231.00M |
| Total Debt | 2.18B |
| Net Cash | -1.95B |
| Net Cash Per Share | -$17.16 |
| Equity (Book Value) | 143.54M |
| Book Value Per Share | 1.26 |
| Working Capital | 588.59M |
Cash Flow
In the last 12 months, operating cash flow was $818.60 million and capital expenditures -$12.37 million, giving a free cash flow of $806.22 million.
| Operating Cash Flow | 818.60M |
| Capital Expenditures | -12.37M |
| Depreciation & Amortization | 106.20M |
| Net Borrowing | 624.57M |
| Free Cash Flow | 806.22M |
| FCF Per Share | $7.10 |
Margins
Gross margin is 76.27%, with operating and profit margins of 56.77% and 24.86%.
| Gross Margin | 76.27% |
| Operating Margin | 56.77% |
| Pretax Margin | 35.06% |
| Profit Margin | 24.86% |
| EBITDA Margin | 63.15% |
| EBIT Margin | 56.77% |
| FCF Margin | 48.46% |
Dividends & Yields
HALO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.21% |
| Shareholder Yield | 4.21% |
| Earnings Yield | 3.37% |
| FCF Yield | 6.57% |
Analyst Forecast
The average price target for HALO is $99.56, which is -7.96% lower than the current price. The consensus rating is "Buy".
| Price Target | $99.56 |
| Price Target Difference | -7.96% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 17.66% |
| EPS Growth Forecast (3Y) | 41.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 10, 2003. It was a forward split with a ratio of 4.275:1.
| Last Split Date | Dec 10, 2003 |
| Split Type | Forward |
| Split Ratio | 4.275:1 |
Scores
HALO has an Altman Z-Score of 4.19 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.19 |
| Piotroski F-Score | 5 |